2016 Interim Update to the Guidelines

Update to the Pharmacologic Management of Type 2 Diabetes

Following the results of recent cardiovascular outcome studies of antihyperglycemic therapies, the recommendations for Pharmacologic Management of Type 2 Diabetes from the 2013 guidelines have been updated. Please refer to the following links to access the published update from the Canadian Journal of Diabetes along with other updated resources on the Guidelines website and App.

Healthcare Provider Tools

Related Chapters

Slides and Videos

2015 Interim Update to the Guidelines

New Addition to the Pharmacologic Management of Type 2 Diabetes

The sodium glucose link transporter 2 (SGLT2) inhibitors have been added to the Pharmacologic Management of Type 2 Diabetes chapter of the 2013 guidelines. Please refer to the following links to access the published update from the Canadian Journal of Diabetes along with other resources on the guidelines website that has been updated.

Healthcare Provider Tools

Related Chapters

Case Studies

Slides and Videos